与Hachimijiogan相关的药物诱导性多炎
Keisuke Kuroda1, Hirofumi Nakazaki1, Yuri Shibata2
1Department of Respiratory Medicine, Tottori Red Cross Hospital, Japan.
Internal medicine (Tokyo, Japan)
|July 30, 2025
概括
一个罕见的药物诱导性肺炎病例在一名老年男子服用日本传统草药hachimijiogan后被诊断出. 停用药物导致症状消失,强调了详细的药物历史在诊断胸腔溢出时的重要性.
科学领域:
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
- 肺部病理学 肺部病理学
背景情况:
- 在没有明确的病因学的情况下,胸腔溢出诊断可能是具有挑战性的.
- 药物诱导的疾病是无法解释的多叶膜溢出的一个重要的差异诊断.
研究的目的:
- 报告一种罕见的药物诱导性肺炎病例,由hachimijiogan引起.
- 强调彻底的药物治疗史在诊断腹腔溢出时的重要性.
主要方法:
- 一个78岁的男性患者的案例研究,表现为左侧多流液.
- 血液和肺部液体的分析,病史审查,药物停用,和意外的重新挑战.
主要成果:
- 对于流的初步诊断测试是不确定的.
- 哈奇米吉冈的使用被确定为潜在的原因.
- 在停止使用hachimijiogan时,多流液消失.
- 意外的重试证实了hachimijiogan作为药物诱导性肺炎的致病原体.
结论:
- 哈奇米吉奥根可以引起药物诱导的肺炎,这是一个罕见的不良反应.
- 详细的药物 anamnesis 对于诊断异常性流至关重要.
- 这是首次报告将hachimijiogan与药物诱导性肺炎联系起来的病例.
相关概念视频
Pericarditis I: Introduction
23
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
23
Pleural Effusion I: Introduction
1.8K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.8K
Pleural Effusion II: Symptoms and Management
272
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
272
Pericarditis III: Medical Management
26
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
26
Myocarditis I: Introduction
30
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
30
Myocarditis III: Medical Management
16
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
16


